[1]
Levy JH, Szlam F, Wolberg AS, Winkler A. Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing. Clinics in laboratory medicine. 2014 Sep:34(3):453-77. doi: 10.1016/j.cll.2014.06.005. Epub 2014 Jul 28
[PubMed PMID: 25168937]
[2]
Triplett DA. Coagulation and bleeding disorders: review and update. Clinical chemistry. 2000 Aug:46(8 Pt 2):1260-9
[PubMed PMID: 10926920]
[3]
van den Besselaar AM, Chantarangkul V, Tripodi A. Thromboplastin standards. Biologicals : journal of the International Association of Biological Standardization. 2010 Jul:38(4):430-6. doi: 10.1016/j.biologicals.2010.02.012. Epub 2010 Mar 24
[PubMed PMID: 20338779]
[4]
Barcellona D, Fenu L, Marongiu F. Point-of-care testing INR: an overview. Clinical chemistry and laboratory medicine. 2017 May 1:55(6):800-805. doi: 10.1515/cclm-2016-0381. Epub
[PubMed PMID: 27754958]
Level 3 (low-level) evidence
[5]
Stein P, Kaserer A, Spahn GH, Spahn DR. Point-of-Care Coagulation Monitoring in Trauma Patients. Seminars in thrombosis and hemostasis. 2017 Jun:43(4):367-374. doi: 10.1055/s-0037-1598062. Epub 2017 Mar 15
[PubMed PMID: 28297730]
[6]
Ebner M, Birschmann I, Peter A, Spencer C, Härtig F, Kuhn J, Blumenstock G, Zuern CS, Ziemann U, Poli S. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants. Critical care (London, England). 2017 Feb 15:21(1):32. doi: 10.1186/s13054-017-1619-z. Epub 2017 Feb 15
[PubMed PMID: 28196509]
[7]
Bolliger D, Tanaka KA. Point-of-Care Coagulation Testing in Cardiac Surgery. Seminars in thrombosis and hemostasis. 2017 Jun:43(4):386-396. doi: 10.1055/s-0037-1599153. Epub 2017 Mar 30
[PubMed PMID: 28359133]
[8]
Hinds PS, Quargnenti A, Gattuso J, Kumar Srivastova D, Tong X, Penn L, West N, Cathey P, Hawkins D, Wilimas J, Starr M, Head D. Comparing the results of coagulation tests on blood drawn by venipuncture and through heparinized tunneled venous access devices in pediatric patients with cancer. Oncology nursing forum. 2002 Apr:29(3):E26-34
[PubMed PMID: 11979291]
[9]
Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clinic proceedings. 2007 Jul:82(7):864-73
[PubMed PMID: 17605969]
[10]
Winter WE, Flax SD, Harris NS. Coagulation Testing in the Core Laboratory. Laboratory medicine. 2017 Nov 8:48(4):295-313. doi: 10.1093/labmed/lmx050. Epub
[PubMed PMID: 29126301]
[11]
Della Valle P,Crippa L,Garlando AM,Pattarini E,Safa O,Viganò D'Angelo S,D'Angelo A, Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Haematologica. 1999 Dec;
[PubMed PMID: 10586206]
[12]
Kremers RMW, Zuily S, Kelchtermans H, Peters TC, Bloemen S, Regnault V, Hemker HC, de Groot PG, Wahl D, de Laat B. Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin. Blood advances. 2018 Jun 12:2(11):1315-1324. doi: 10.1182/bloodadvances.2018018036. Epub
[PubMed PMID: 29895622]
Level 3 (low-level) evidence
[13]
Hellenbart EL, Faulkenberg KD, Finks SW. Evaluation of bleeding in patients receiving direct oral anticoagulants. Vascular health and risk management. 2017:13():325-342. doi: 10.2147/VHRM.S121661. Epub 2017 Aug 23
[PubMed PMID: 28860793]
[14]
Kim JA, Kim JE, Song SH, Kim HK. Influence of blood lipids on global coagulation test results. Annals of laboratory medicine. 2015 Jan:35(1):15-21. doi: 10.3343/alm.2015.35.1.15. Epub 2014 Dec 8
[PubMed PMID: 25553275]